Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

11.90p
   
  • Change Today:
      0.70p
  • 52 Week High: 12.20
  • 52 Week Low: 6.55
  • Currency: UK Pounds
  • Shares Issued: 500.00m
  • Volume: 5,217,067
  • Market Cap: £59.50m

Poolbeg Pharma Overview

Poolbeg Pharma is a clinical stage infectious disease pharmaceutical company, with a capital light clinical model which the Directors believe enables it to develop multiple products faster and more cost effectively than the traditional biotech model. Poolbeg has aspirations to become the “one-stop shop” for Big Pharma seeking mid-stage products to license or acquire.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 3.9  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Poolbeg Pharma Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 n/a (2.34) (0.74)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (4.78) (0.94)p n/a n/a n/a n/a 0.0%
31-Dec-23 n/a (4.51) (0.79)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Poolbeg Pharma Company Announcements

Appointment of Joint Broker 30-Apr-2024 07:02 RNS
Option Agreement to Acquire Orphan Drug Candidate 30-Apr-2024 07:01 RNS
Results for the year ended 31 December 2023 30-Apr-2024 07:00 RNS

Poolbeg Pharma ShareCast News

Poolbeg Pharma to be granted US patent 20-Mar-2024 ShareCast
Director dealings: Poolbeg Pharma co-founder ups... 19-Feb-2024 ShareCast
Poolbeg upbeat on research into potential drug m... 12-Feb-2024 ShareCast

Latest Poolbeg Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 11.90p
Change Today 0.70p
% Change 6.25 %
52 Week High 12.20
52 Week Low 6.55
Volume 5,217,067
Shares Issued 500.00m
Market Cap £59.50m

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
62.35% below the market average62.35% below the market average62.35% below the market average62.35% below the market average62.35% below the market average
45.1% below the sector average45.1% below the sector average45.1% below the sector average45.1% below the sector average45.1% below the sector average
Price Trend
95.75% above the market average95.75% above the market average95.75% above the market average95.75% above the market average95.75% above the market average
96.43% above the sector average96.43% above the sector average96.43% above the sector average96.43% above the sector average96.43% above the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 30-Apr-2024

Time Volume / Share Price
14:33 2,500 @ 11.80p
14:33 1,287 @ 11.90p
14:27 18,000 @ 11.80p
14:26 40,904 @ 11.95p
14:24 2,768 @ 11.89p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page